Literature DB >> 2943588

Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.

M Trautmann, B Krause, D Birnbaum, J Wagner, V Lenk.   

Abstract

The bactericidal activity of two newer quinolones, ciprofloxacin and ofloxacin, against eight strains of Salmonella typhi was examined by the serum dilution test and studies of bacterial killing kinetics in human serum, and compared to standard regimens. Bactericidal titers for ciprofloxacin ranged from 1:388 to 1:119 two hours and from 1:119 to 1:57 six hours after volunteers received an oral dose of 500 mg. The respective titers obtained after a 200 mg oral dose of ofloxacin were somewhat lower, but still exceeded 1:16 in all instances. Studies of bacterial killing kinetics demonstrated a rapid bactericidal action of both drugs against all strains tested. Compared to the classical anti-typhoid agents chloramphenicol, cotrimoxazole and amoxicillin, the new quinolones showed both markedly higher bactericidal titers and more rapid killing of Salmonella typhi in human serum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2943588     DOI: 10.1007/bf02017785

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  26 in total

1.  The problem and implications of chloramphenicol resistance in the typhoid bacillus.

Authors:  E S Anderson
Journal:  J Hyg (Lond)       Date:  1975-04

2.  A method of determining the effective therapeutic level in the treatment of subacute bacterial endocarditis with penicillin; a preliminary report.

Authors:  J G SCHLICHTER; H MAC LEAN
Journal:  Am Heart J       Date:  1947-08       Impact factor: 4.749

3.  The bactericidal activity in serum and its prognostic clinical value.

Authors:  J Klastersky
Journal:  Infection       Date:  1983       Impact factor: 3.553

4.  Serum dilution test for bactericidal activity. I. Selection of a physiologic diluent.

Authors:  C W Stratton; L B Reller
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

5.  Trimethoprim-sulphamethoxazole in the treatment of enteric fever in the Sudan.

Authors:  E D Mukhtar; M O Mekki
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

6.  Chloramphenicol in the treatment of enteric fever.

Authors:  C Herzog; A M Geddes
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

7.  Treatment of typhoid fever with cefamandole.

Authors:  M Uwaydah; N T Nassar; H Harakeh; S Vartivarian; A Talhouk; H Kantarjian
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.

Authors:  Y Van Laethem; H Lagast; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

9.  Management of enteric fever with amdinocillin.

Authors:  A P Ball; A M Geddes
Journal:  Am J Med       Date:  1983-08-29       Impact factor: 4.965

10.  Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.

Authors:  R Platt; S L Ehrlich; J Afarian; T F O'Brien; J E Pennington; E H Kass
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

View more
  3 in total

Review 1.  Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Authors:  John A Crump; Maria Sjölund-Karlsson; Melita A Gordon; Christopher M Parry
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

Review 2.  Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; J P Monk; A Price; P Benfield; P A Todd; A Ward
Journal:  Drugs       Date:  1988-04       Impact factor: 9.546

Review 3.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.